News About: Pharm. Industry
Choong-wae Pharm strengthens its domestic presence by acquiring exclusive marketing right to GABITRI
Choong-wae Pharm said recently that for the local introduction of Gabitril tablet (tiagabine HCl), an antiepilepsy drug, it entered into another exclusive distribution agreement with the U.S.-based Anesta Corporation,...
KHIDI to subsidy bio Industry in Chooncheon area.
The KHIDI (President: Mr. Lee Kyeong-ho) has recently made an agreement with Chooncheon Bio Industry Development Institute(CBIDI) (Head: Mr. Yoo Jong-soo) for the technology trade and assessment, and decided to explor...
Health Industry Venture Group to have a strategic conference.
The Health Industry Venture Association (HIVA), a judicial corporation, (President: Mr. Park In-chool) plans to have a strategic conference titled "A forum invited civilian and government officials for the strategic f...
China, world's fifth largest pharmaceutical market by 2010
China's pharmaceutical market will rank fifth in the world in terms of size, according to a study released by the 4th pharmaceutical industry forum in Asia-Pacific region.
The study said that the nation ranked seve...
Organon Korea to open Implanon call center
Organon Korea said it has been operating its free call center for Implanon, a rod-type contraceptive, as part of its efforts to beef up the customer-friendly service.
According to the company, the call center (phon...
KHIDI's disclosed support program for medicinal industries
The Korea Health Industry Development Institute (KHIDI) reported their 2004 support programs for the medicinal industries covering the industrial approval and the formation of the pharmaceutical industry development c...
Sanofi-Synthelabo Group achieved 15% of sales up last year.
Sanofi-Synthelabo group reported their business performances during 2003 on Feb. 17 describing, to compare to the previous year, 15.6% up of the net sales with 8,048 million Euro dollars (about 11 trillion won), 17.6%...
Domestic pharmaceutical firms rush to launch off-patent drugs
Korea's local pharmaceutical makers are scrambling to introduce a wider variety of first generic products with bigger market potentiality this year in a to have a strong foothold in the domestic ethical market...
Number of new drug wholesalers plunged sharply
There have been positive signs in the domestic wholesaling industry that the number of new small wholesalers is in a downward trend, an indication that this may significantly contribute to a firmer establishment of dr...
Samjin Pharm to form venture in tripartite partnership
Samjin Pharm, Korea's leading pharmaceutical maker, said recently that it has set up a joint venture with two foreign partners in India and U.K., as part of Samjin's effort to expand its pharmaceutical business in the...
